Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.

@article{Nguyen2012RanibizumabFD,
  title={Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.},
  author={Quan D. Nguyen and David M. Brown and Dennis M. Marcus and David S Boyer and Sunil S. Patel and Leonard Feiner and Andrea Gibson and Judy P. Sy and Amy Chen Rundle and Jill J. Hopkins and Roman G. Rubio and Jason S Ehrlich},
  journal={Ophthalmology},
  year={2012},
  volume={119 4},
  pages={789-801}
}
PURPOSE To evaluate the efficacy and safety of intravitreal ranibizumab in diabetic macular edema (DME) patients. DESIGN Two parallel, methodologically identical, phase III, multicenter, double-masked, sham injection-controlled, randomized studies. PARTICIPANTS Adults with vision loss from DME (best-corrected visual acuity [BCVA], 20/40-20/320 Snellen equivalent) and central subfield thickness ≥275 μm on time-domain optical coherence tomography (OCT). INTERVENTION Monthly intravitreal… CONTINUE READING
Highly Influential
This paper has highly influenced 33 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS

From This Paper

Topics from this paper.
319 Citations
11 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 319 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 11 references

Arch Ophthalmol. Feb

  • Arch Ophthalmol. Feb
  • 2012

PARTICIPANTS: The eyes of 4 patients taking vitamin supplementation for ARMD were examined at the University of Pittsburgh Medical Center Department of Ophthalmology between

  • PARTICIPANTS: The eyes of 4 patients taking…
  • 2010

DESIGN: Retrospective single-center case series

  • DESIGN: Retrospective single-center case series

Disclaimer: This newsletter is provided as a free service to eye care professionals by the Macular Degeneration Foundation

  • Disclaimer: This newsletter is provided as a free…

METHODS: We reviewed the medical records of 4 patients with peripheral corneal rings receiving vitamin supplementation for ARMD

  • METHODS: We reviewed the medical records of 4…

PMID: 22330962 [PubMed -as supplied by publisher

  • PMID: 22330962 [PubMed -as supplied by publisher

PMID: 22332227 [PubMed -in process

  • PMID: 22332227 [PubMed -in process

PURPOSE: To report the first described cases of peripheral yellow corneal rings secondary to vitamin supplementation for age-related macular degeneration (ARMD)

  • PURPOSE: To report the first described cases of…

The Macular Degeneration Foundation cannot be liable for any error or omission in this publication and makes no warranty of any kind, either expressed or implied in relation to this publication

  • The Macular Degeneration Foundation cannot be…

Similar Papers

Loading similar papers…